USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Celltrion Inc.

USPTO PatentsView assignee record - 29 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Celltrion ranks #10,573 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 16 technology areas.

#10,573
of 49,997 US assignees by volume
Top 39%
by Innovation Score (39.3/100)
12.3
avg claims per patent
+45%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10573 · Foreign Corporation #10,573 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 29 grants
  • UPPER-Q #10,573/49,997
  • PHOTO-FINISH C4 Therapeutics
  • CPC-FOCUS A61K · 16 areas
  • INNOV-THIN 39.3/100
  • CLAIMS-RICH 12.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +45% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: C4 Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Celltrion’s 39.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Celltrion

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Celltrion's Innovation Score is 39.3/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Celltrion?

Each dot is one of Celltrion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Celltrion’s own 12.3 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Celltrion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 28.92929.1 101520253035 Granted patents (volume) Avg claims / patent C4 Therapeutics, Inc. - 29, 20.86C4 TherapeuticsCalgon Carbon Corporation - 29, 17.48Calgon CarbonCalithera Biosciences, Inc. - 29, 30.03Calithera Bioscie…Cbrite Inc. - 29, 21.83CbriteCentre Leon Berard - 29, 13.72Centre Leon BerardChina Communication Technology Co., Ltd. - 29, 11.62China Communicati…Cloud Network Technology Singapore PTE. Ltd. - 29, 14.55Cloud Network Tec…CMC Materials LLC - 29, 15.62CMC MaterialsCelltrion Inc. - 29, 12.28Celltrion
Celltrion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Celltrion's grants concentrate

Celltrion Inc. is a focused PatentsView assignee: 16 CPC subclasses with 79.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2015. By volume, Celltrion sits between C4 Therapeutics, Inc. and CMC Materials LLC.

Celltrion's three-year grant acceleration

Celltrion Inc. shows 9 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Celltrion's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Celltrion holds 29 patents at rank #10,572, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Celltrion

By rank, the assignees closest to #10,572 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Celltrion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Celltrion, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Celltrion ranks #978 of 7,163 assignees by patent count in that subclass.

Celltrion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 20152016201720182019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Celltrion Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 3.4%
2016 3 10.3%
2017 3 10.3%
2018 1 3.4%
2019 3 10.3%
2020 3 10.3%
2021 4 13.8%
2022 2 6.9%
2023 3 10.3%
2024 4 13.8%
2025partial year 2 6.9%

Which technologies does Celltrion Inc. patent most?

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Celltrion Inc.'s patent record in context - here's where to go next.

  • Celltrion Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 79.3% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #10,573 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Celltrion Inc. against C4 Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.